VAXELIS susp inj avec 1 aiguille 10 ser pré 0.5 ml
7680669400033
CH-66940
J07CA09
08.08.
Active substances:
Reimbursement limitations:
BLUTPRODUKTE
Calcul des prix des préparations sanguines sur la base du prix « ex factory », …
1 / 3
google
Details
- Product number
- 6694001
- CPT
- -
- Packaging group
- 10
- Unit
- Fertigspritze(n)
- Composition
- polysaccharida haemophili influenzae typus B conjugata cum proteino neisseriae meningitidis B 53 µg corresp. polysaccharida haemophili influenzae typus B 3 µg et neisseria meningitidis B outer membrane protein complex 50 µg, hepatitidis B viri antigenum ADNr 10 µg, toxoidum pertussis 20 µg, haemagglutininum filamentosum 20 µg, pertactinum 3 µg, fimbriae Typ 2 und 3 5 µg, toxoidum diphtheriae min. 20 U.I., toxoidum tetani min. 40 U.I., virus poliomyelitis typus 1 inactivatus (Mahoney) 29 U., virus poliomyelitis typus 2 inactivatus (MEF-1) 7 U., virus poliomyelitis typus 3 inactivatus (Saukett) 26 U., aluminium ut aluminii phosphas et aluminii hydroxyphosphas sulfas amorphus, natrii phosphates, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.95 mg, residui: glutaralum, formaldehydum, neomycinum, streptomycinum, polymyxinum B, albuminum seri bovis, aluminii thiocyanas, faecis proteina.
Articles (1)
Vaxelis 0.5 ml, Injektionssuspension
Injektionssuspension
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
polysaccharida haemophili influenzae typus B conjugata cum proteino neisseriae meningitidis B
|
53.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida haemophili influenzae typus B
|
3.0 UG | Substance | WIIS |
|
neisseria meningitidis B outer membrane protein complex
|
50.0 UG | Substance | WIIS |
|
hepatitidis B viri antigenum ADNr
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
20.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
3.0 UG | Substance | Wirkstoff (Principe actif) |
|
fimbriae
|
5.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
29.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
7.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
26.0 U | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
- | Substance | HIMDK |
|
aluminii phosphas
|
- | Substance | HNIDK |
|
aluminii hydroxyphosphas sulfas amorphus
|
- | Substance | HNIDK |
|
natrii phosphates
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
1.95 MG | Substance | HBESI |
|
glutaralum
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
|
neomycinum
|
- | Substance | RESI |
|
streptomycinum
|
- | Substance | RESI |
|
polymyxinum B
|
- | Substance | RESI |
|
albuminum seri bovis
|
- | Substance | RESI |
|
aluminii thiocyanas
|
- | Substance | RESI |
|
faecis proteina
|
- | Substance | RESI |
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 66940
- Drug name
- Vaxelis, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07CA09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/08/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VAXELIS susp inj avec 1 aiguille 10 ser pré 0.5 ml
- Description (DE)
- VAXELIS Inj Susp mit 1 Nadel 10 Fertspr 0.5 ml
- Market launch
- 28/08/2019
- Narcotic (BTM)
- No